Paeds SAQs · endocrinology-diabetes-and-growth
Cushing syndrome in children — formative SAQs
Two formative SAQs on Cushing syndrome in children: the obese adolescent whose height has fallen off the centiles, and the Cushingoid child with a clear inhaled-steroid history, testing the growth-arrest discriminator, the three-test confirmatory work-up, ACTH localisation, and the perioperative glucocorticoid replacement that prevents adrenal crisis.
On this page
Study tools
Target exams
SAQ 1 — The adolescent who stopped growing (20 marks, ~15 minutes)
A 13-year-old girl presents with an eight-month history of weight gain, a round face, purple abdominal striae and fatigue. Her mother reports worsening mood and falling school marks. On the growth chart her weight has risen from the 75th to beyond the 95th centile, while her height has crossed down from the 50th to the 10th centile. Her blood pressure is 142/90. [1]
Questions
- Give the most likely diagnosis and the single bedside feature that distinguishes it from simple obesity. (4 marks) [1]
- Outline the confirmatory biochemical work-up, naming the three first-line tests and the principle that you use at least two. (5 marks) [3]
- Once cortisol excess is confirmed, describe the localising step and the role of inferior petrosal sinus sampling. (5 marks) [5]
- State the first-line definitive treatment and the perioperative medication that is mandatory to prevent adrenal crisis after cure. (6 marks) [6]
Model answer (must-hit)
- This is Cushing syndrome (most likely pituitary Cushing disease). The discriminator from simple obesity is growth arrest — height crossing centiles downward while weight rises. In simple exogenous obesity the child is tall or growing normally, often with an advanced bone age, because over-nutrition drives growth; cortisol suppresses the growth-hormone axis. [1]
- Confirm with at least two of three first-line tests: a late-night (midnight) salivary or serum cortisol (loss of the diurnal rhythm is the earliest and most sensitive change), a 24-hour urinary free cortisol, and an overnight dexamethasone suppression test (dexamethasone 15 µg per kilogram capped at 1 mg; an 8 am cortisol not suppressed below 1.8 µg per decilitre supports Cushing). Two tests are used because no single test is perfect and the disease is cyclic. [3]
- Measure plasma ACTH. A high or inappropriately normal ACTH means ACTH-dependent disease (pituitary or, rarely, ectopic); a suppressed low ACTH means ACTH-independent adrenal disease. For ACTH-dependent disease, image the pituitary with dynamic gadolinium MRI. When the MRI is negative or non-lateralising, bilateral inferior petrosal sinus sampling confirms a pituitary source and helps lateralise the adenoma — a central-to-peripheral ACTH ratio above two at baseline, or above three after corticotrophin-releasing hormone, confirms pituitary Cushing disease. [5]
- First-line treatment for pituitary Cushing disease is transsphenoidal selective adenomectomy by an experienced surgeon, with remission in roughly seventy to ninety percent of paediatric cases. The mandatory perioperative medication is stress-dose glucocorticoid, because the cured child's suppressed pituitary-adrenal axis cannot generate cortisol and tips into adrenal insufficiency within hours to days. Replace glucocorticoid until the axis recovers, often six to eighteen months. [6]
References6ShowHide
- [1]Magiakou MA; Mastorakos G; Oldfield EH; et al Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med, 1994.PMID 8052272
- [3]Nieman LK; Biller BM; Findling JW; et al The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2008.PMID 18334580
- [4]Nieman LK; Biller BM; Findling JW; et al Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2015.PMID 26222757
- [5]Lacroix A; Feelders RA; Stratakis CA; Nieman LK Cushing's syndrome. Lancet, 2015.PMID 26004339
- [6]Kanter AS; Diallo AO; Jane JA Jr; et al Single-center experience with pediatric Cushing's disease. J Neurosurg, 2005.PMID 16302612
- [9]Ferrigno R; Hasenmajer V; Caiulo S; et al Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome. Rev Endocr Metab Disord, 2021.PMID 33515368